GLP-1 medicines linked to reduced fracture risk in type 2 diabetes patients

A large observational study suggests that GLP-1 receptor agonists may offer protective benefits against fragility fractures in older adults with type 2 diabetes, raising hopes for broader skeletal health effects beyond glucose regulation. A large observational study has added to…















